BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 2, 2026
Home » Topics » Conferences

Conferences
Conferences RSS Feed RSS

Cancer

Kinensus designs and tests AXL/MER inhibitors

Nov. 18, 2022
The TAM family of receptor tyrosine kinases...
Read More
Immuno-oncology

Encouraging preclinical results reported for ASKG-915, a new cytokine prodrug fusion protein

Nov. 18, 2022
Researchers from Askgene Pharma Inc...
Read More
Liver disease
Gastrointestinal

ID-119031166 improves NASH and liver fibrosis in hamsters

Nov. 18, 2022
ID-119031166 is a non-bile acid farnesoid X...
Read More
Neurons
Neurology/Psychiatric

Intra-DRG administration of RLVT-14-02 effective against neuropathic pain in preclinical model

Nov. 18, 2022
Neuropathic pain (NP) is caused by damage or...
Read More
Paralysis patients walk again following epidural electrical stimulation.
Neurology/Psychiatric

Neuroscience 2022: Recording brain signals to restore talk and movement

Nov. 17, 2022
By Mar de Miguel
Stimulating the brain via implanted electrodes is used to treat both movement disorders such as Parkinson’s disease, and some psychiatric conditions such as obsessive compulsive disorder. But researchers are also working on ways to make such implanted electrodes listen instead of talk – and translate neuronal signals for people that have lost the ability speak, or the ability to move.
Read More
Brain and encephalography
Neurology/Psychiatric

CACNB3 as novel therapeutic target in mesial temporal lobe epilepsy

Nov. 17, 2022
Investigators at the University of Copenhagen and affiliated organizations presented data from a study that aimed to validate differentially expressed genes (DEGs) in mesial temporal lobe epilepsy (mTLE) as potential new targets.
Read More
Cancer cells being destroyed by immunotherapy
Immuno-oncology

Anti-EPN1 antibody enhances the efficacy of anti-PD-L1 therapy in model of melanoma

Nov. 17, 2022
Epsin 1 (EPN1) is an adapter protein involved in clathrin-mediated endocytosis and upregulated in multiple cancers.
Read More
Neurology/Psychiatric

Mindset Pharma presents preclinical data on MSP-1014

Nov. 17, 2022
Psilocybin is a prodrug of psilocin, which is thought to mediate antidepressant effects...
Read More
Central nervous system
Neurology/Psychiatric

RTI-122 as a potent GPR88 agonist for CNS-related disorders

Nov. 17, 2022
RTI International has presented results on RTI-122, a G protein-coupled receptor 88...
Read More
Joint pain
Neurology/Psychiatric

NIP-322: a novel treatment for osteoarthritis pain

Nov. 17, 2022
Increased levels of tetrahydrobiopterin (BH4) are linked to pain sensitivity in humans...
Read More
Previous 1 2 … 278 279 280 281 282 283 284 285 286 … 3205 3206 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 1, 2026.
  • Floating antibody drug conjugates

    TROP2 ADCs progress into first-line for lung, breast cancers

    BioWorld
    Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
  • Illustration of antibodies and viral infection

    New evidence links autoimmunity to long COVID symptoms

    BioWorld
    Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
  • Liver with hepatitis viruses, blood cells

    Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections

    BioWorld
    GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
  • Healthy (left) vs. cancerous bone marrow

    BMS’ mezigdomide doubles PFS in multiple myeloma

    BioWorld
    Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing